FHIRsmith: FHIR Resources

FHIR IG analytics

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | pt | se | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds

270,995 resources (JSON | CSV)

Type:
Text: Package: Only Show Used

By Version

R2: 117
R2B: 0
R3: 21,787
R4: 158,444
R4B: 43,719
R5: 32,499
R6: 2,222

By Authority

none: 189,580
hl7: 74,857
ihe: 1,324
national: 3,888
who: 1,346

By Realm

none: 183,568
au: 736
be: 606
br: 400
ca: 1,464
ch: 1,776
cl: 564
cr: 117
cz: 862
de: 2,090
dk: 1,497
ee: 260
eu: 967
fi: 87
fr: 3,334
il: 328
in: 163
it: 116
jp: 174
kr: 30
nl: 2,247
no: 125
nz: 240
pl: 258
pt: 50
se: 161
stt: 116
tw: 1,414
uk: 6
us: 23,032
uv: 44,063
vn: 108
other: 6

Start Prev Rows 226000 - 226200 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth	Usage #
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.387.json	RET test_Thyroid_cancer (HGNC)	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.388.json	RET Positive	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.389.json	NSCLC N3 Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.390.json	CRC Cancer Diagnosis ICD9	active	2024-08	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.391.json	CRC Cancer Diagnosis ICD10	active	2024-08	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.392.json	CRC Cancer Diagnosis ICD9/ICD10	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.393.json	Metastatic_CRC_Cancer_Stage Group	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.394.json	Locally_Advanced_Localized_CRC_Stage Group	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.395.json	CRC cancer M Stage (metastatic)	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.396.json	CRC Cancer T Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.397.json	CRC Cancer N Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.398.json	KRAS_gene	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.399.json	KRAS_negative	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.40.json	Locoregional Breast Cancer	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.400.json	Fluoropyrimidine_CRC	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.401.json	Oxaliplatin	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.402.json	Irinotecan_based_therapy	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.403.json	anti_VEGF_therapy_CRC	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.404.json	anti_EGFR_therapy_CRC	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.405.json	fruquitinib	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.406.json	Locally_Advanced_CRC_Stage Group	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.407.json	Localized_CRC_Stage Group	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.408.json	CRC cancer M0_Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.409.json	CRC_Cancer_T1_Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.410.json	CRC_Cancer_T2_Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.411.json	CRC_Cancer_T3_Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.412.json	CRC_Cancer_T4_Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.413.json	CRC Cancer N1 Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.414.json	CRC Cancer N2 Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.415.json	CRC Cancer N2b Stage	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.416.json	KRAS_G12C_MV	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.417.json	KRAS_G12C_PM	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.418.json	KRAS_positive	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.419.json	Adagrasib	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.42.json	Breast Cancer	active	2023-10	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.420.json	cetuximab_therapy	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.421.json	Tamoxifen_therapy	active	2024-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.423.json	Endometrial Cancer Diagnosis ICD 10	active	2024-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.425.json	Endometrial Cancer Diagnosis ICD9CM	active	2024-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.426.json	Endometrial Cancer Diagnosis	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.428.json	Localized_Endometerial_Stage Group SNOMED	active	2024-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.429.json	Localized_Endometerial_Stage Group NCIM	active	2024-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.431.json	Endometrial_Sarcoma_Tumor_Histology_exc	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.432.json	Endometrial cancer M Stage (metastatic)	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.433.json	Endometrial_M0_Stage	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.436.json	Prior_therapy_Endometrial	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.437.json	Paclitaxel_therapy	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.441.json	Carboplatin_therapy	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.442.json	Durvalumab_therapy	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.444.json	MMR_Gene_Lab_LOINC	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.447.json	MMR_Gene_HGNC	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.449.json	Endometrial_ Cancer N Stage	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.451.json	Endometrial_N0_Stage	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.453.json	Endometrial_N1_N2_Stage	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.455.json	Endometrial_T1_T3_Stage	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.456.json	Endometrial_T3_Stage	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.458.json	Endometrial_T4_Stage	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.459.json	Endometrial Cancer T Stage	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.46.json	Endometrial Cancer ICD10	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.460.json	Localized_Endometerial_Stage Group_SNOMED/NCIM	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.461.json	Metastatic Sites All CRC	active	2024-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.462.json	Metastatic Sites All CRC ICD 10	active	2024-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.463.json	Metastatic Sites All CRC ICD 9	active	2024-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.464.json	Metastatic Sites All CRC (grouped, SNOMEDCT/ICD9/ICD10)	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.465.json	NTRK Repotrectinib Molecular Variants	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.466.json	NTRK_Gene_rearrangment	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.467.json	Prior_Systemic_therapy_Repotrectinib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.468.json	NTRK_Positive	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.469.json	NTRK_test_gene	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.47.json	Systemic treatment for endometrial cancer	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.470.json	Tamoxifen_Trodelvy	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.471.json	Toremifene_trodelvy	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.472.json	Fulvestrant_Trodelvy	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.473.json	Elacestrant	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.474.json	Anastrozole_Trodelvy	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.475.json	Leuprolide_Trodelvy	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.476.json	Abemaciclib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.477.json	Palbociclib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.478.json	Ribociclib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.479.json	Carboplatin_Trodelvy	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.48.json	Endometrial Cancers	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.480.json	Cisplatin_Trodelvy	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.481.json	Cyclophosphamide	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.482.json	Methotrexate	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.483.json	Gemcitabine	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.484.json	Capecitabine	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.485.json	Eribulin	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.486.json	Doxorubicin	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.487.json	Vinorelbine	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.488.json	Epirubicin	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.489.json	Ixabepilone	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.490.json	Olaparib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.491.json	Talazoparib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.492.json	Entrectinib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.493.json	larotrectinib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.494.json	Alpelisib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.495.json	Capivasertib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.496.json	Pembrolizumab	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.497.json	Dostarlimab	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.498.json	Selpercatinib	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.499.json	Everolimus	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.500.json	Trastuzumab_deruxtecan	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.501.json	Test 23	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.502.json	All Metastatic sites Endometrial SNOMED	active	2024-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.503.json	All Metastatic sites Endometrial ICD9	active	2024-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.504.json	All Metastatic sites Endometrial ICD10	active	2024-09	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.505.json	All Metastatic sites Endometrial	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.506.json	Create CRC_Cancer_T4a_Stage	active	2024-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.507.json	Create CRC_Cancer_T4b_Stage	active	2024-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.508.json	High Emetogenic Risk Chemotherapy	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.510.json	InactiveFollowup	active	2025-05	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.53.json	MMR Gene Testing	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.54.json	MSI High	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.55.json	MSI High	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.6.json	Orserdu	active	2023-08	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.61.json	Stage IIB or lower and limited	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.62.json	Stage III or higher	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.63.json	Stage III or higher	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.64.json	Stage III or higher	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.65.json	Staging Unknown	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.66.json	Staging Unknown	active	2023-11	us	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.67.json	Staging Unknown	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.68.json	Jemperli	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.69.json	Uterine Sarcoma	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.7.json	Her2 Test For Orserdu	active	2023-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.70.json	Tumor Histology	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.71.json	Platinum based therapy	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.72.json	Prior Therapies for Tucatinib	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.73.json	Tucatinib	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.74.json	Colorectal Cancer ICD10	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.75.json	Colorectal Cancer ICD9	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.76.json	Colorectal Cancer ICD9 and ICD10	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.78.json	Advanced or Unresectable Colorectal Cancer Staging	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.79.json	0 to IIIB Colorectal Cancer Staging	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.80.json	Colorectal Cancer M1 Stage	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.81.json	RAS Genes	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.82.json	RAS Gene Interpretation Negative LOINC	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.83.json	RAS Gene Interpretation Negative SNOMED	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.84.json	RAS Gene Interpretation Negative NCM	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.85.json	RAS Gene Negative	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.86.json	RAS Gene Interpretation Positive SNOMED	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.87.json	RAS Gene Interpretation Positive LOINC	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.88.json	RAS Gene Positive	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.89.json	Her2 Testing	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.90.json	Patient Reason	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.91.json	MSI High NCI	active	2024-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.92.json	MSI Low SNOMED	active	2024-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.93.json	MSI Low LOINC	active	2024-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.94.json	MSI Low NCI	active	2024-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.95.json	MSI Low	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.96.json	MMR Deficient NCI	active	2024-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.97.json	MMR Proficient SNOMED	active	2024-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.98.json	MMR Proficient LOINC	active	2024-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1260.99.json	MMR Proficient NCI	active	2024-01	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1262.3.json	ICD9 Codes for HIV Diagnosis	active	2023-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.1.json	Inpatient Pneumonia Diagnosis	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.11.json	Chest Imaging for Pneumonia, HCPCS	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.12.json	Chest Imaging for Pneumonia Grouping Definition	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.18.json	ICD9 Abnormal Finding on Chest Imaging	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.19.json	ICD10 Abnormal Finding on Chest Imaging	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.2.json	ICD9 Pneumonia Definition	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.20.json	SNOMEDCT Abnormal Finding on Chest Imaging	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.21.json	Abnormal Finding on Chest Imaging	active	2023-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.22.json	SNOMEDCT Pneumonia Definition	active	2023-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.23.json	CAP Concurrent Infections	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.24.json	CAP Pneumonia Diagnostic	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.25.json	Antibiotic Usage for CAP Diagnosis	active	2024-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.27.json	Legionella Presence by Urine Antigen or DNA	active	2024-09	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.29.json	Broad Spectrum Antibiotics for MDRO	active	2024-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.3.json	ICD10 Pneumonia Definition	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.32.json	CPT Transplants, Stem Cell and Solid	active	2024-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.33.json	HCPCS Transplant, Stem Cell and Solid	active	2024-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.34.json	ICD10CM Transplant, Stem Cell and Solid	active	2024-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.35.json	ICD10PCS Transplant, Stem Cell and Solid	active	2024-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.37.json	SNOMEDCT Transplant, Stem Cell and Solid	active	2024-12	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.38.json	Transplant, Stem Cell and Solid	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.39.json	Antibiotic Usage for CAP Duration	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.40.json	CAP Sepsis Diagnostic	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.41.json	CAP Respiratory Failure Diagnostic	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.42.json	MRSA Organism or Substance in Lab Results	active	2024-12	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.8.json	Systemic Antimicrobials	active	2023-11	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1264.9.json	Chest Imaging for Pneumonia, CPT	active	2023-11	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.1.json	Problem Type	active	2025-04	us	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.10.json	Information Source for Medication Adherence HSLOC	active	2024-03	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.11.json	Information Source for Medication Adherence	active	2024-03	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.14.json	Unknown and Asked but Unknown (DAR)	active	2024-10	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.15.json	Yes or No SCT	active	2024-10	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.16.json	Answer Set with Yes No and Unknowns	active	2024-10	us	hl7	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.17.json	Common LOINC Lab Codes	active	2024-10	us	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.18.json	Radiology Procedures (LOINC)	active	2024-10	us	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.21.json	Universal Common LOINC Lab Orders	active	2024-10	us	hl7
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.22.json	Route of Administration of Therapeutic Agents	active	2024-10	us	hl7	3
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.23.json	Encounter Type	active	2025-05	us	hl7	4
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.27.json	Social History Type (LOINC)	active	2025-05	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.28.json	Social History Type	active	2025-04	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.3.json	Smoking status comprehensive	active	2024-02	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.4.json	Smoking Status Type LOINC	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.5.json	Smoking Status Pack Years SCT	active	2024-02	us	hl7	1
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.6.json	Smoking Status Type	active	2024-02	us	hl7	2
us.nlm.vsac	R4	ValueSet/ValueSet-2.16.840.1.113762.1.4.1267.7.json	Information Source for Medication Adherence HL7 Role Code	active	2024-03	us	hl7	1